The American Journal of Cardiology · Nov 18, 2026
Artificial Intelligence and Cardiovascular Disease Prevention: Newton's Second Law Readdressed with a Cautionary Note
By Ram CVS, Parati G
The persistent burden of cardiovascular disease (CVD) reflects not simply a lack of concrete evidence, but limitations in identifying risk early, characterizing its complexity, and translating risk information into timely and sustained intervention. Cardiovascular prevention has evolved from assessment of individual risk factors toward estimation of absolute global cardiovascular risk and expected treatment benefit. However, conventional approaches remain largely static and constrained by the data routinely available in clinical practice. Artificial intelligence (AI) offers an opportunity to provide the technological acceleration needed to strengthen the Force of cardiovascular prevention, in line with Newton’s second law. This review discusses how AI can integrate multimodal and longitudinal data from various clinical assessments to improve risk prediction, uncover latent cardiovascular phenotypes, and characterize evolving individual risk trajectories. Hence, it can enable earlier detection of subclinical disease, continuous monitoring, personalized interventions, and population-level identification of missed preventive opportunities. Finally, the review highlights how the future value of AI in cardiovascular prevention will depend on its ability to move beyond prediction toward risk modification and reductions in cardiovascular events and mortality, in a sustainable and equitable manner.
doi.org/10.1016/j.amjcard.2026.11.010PubMed 43051345Biomarkers